Richard G Wunderink
Overview
Explore the profile of Richard G Wunderink including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
269
Citations
11235
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gao C, Markov N, Pickens C, Pawlowski A, Kang M, Walter J, et al.
Open Forum Infect Dis
. 2025 Mar;
12(3):ofaf090.
PMID: 40046892
Background: Critically ill patients who develop invasive pulmonary aspergillosis (IPA) have high mortality rates despite antifungal therapy. Diagnosis is difficult in these patients and incidences vary in the literature. Bronchoalveolar...
2.
Guggilla V, Kang M, Bak M, Tran S, Pawlowski A, Nannapaneni P, et al.
medRxiv
. 2025 Jan;
PMID: 39867358
Identifying immunosuppressed patients using structured data can be challenging. Large language models effectively extract structured concepts from unstructured clinical text. Here we show that GPT-4o outperforms traditional approaches in identifying...
3.
Ramirez J, Hubler R, Ali M, Gray S, Carrico R, McNaughton C, et al.
Open Forum Infect Dis
. 2025 Jan;
12(1):ofae727.
PMID: 39758745
Background: Serotype-specific urinary antigen detection (UAD) assay results can be used to estimate the serotype contribution among adults with pneumococcal community-acquired pneumonia (CAP) and to guide recommendations regarding higher-valency pneumococcal...
4.
Kutty P, Jain S, Diaz M, Self W, Williams D, Zhu Y, et al.
Int J Med Sci
. 2024 Dec;
21(15):3003-3009.
PMID: 39628678
The burden and epidemiology of (Mp) community-acquired pneumonia (CAP) among hospitalized U. S. adults (≥ 18 years) are poorly understood. In the Etiology of Pneumonia in the Community (EPIC) study,...
5.
Zhu M, Pickens C, Markov N, Pawlowski A, Kang M, Rasmussen L, et al.
medRxiv
. 2024 Sep;
PMID: 39314979
Background: Antibiotic stewardship in critically ill pneumonia patients is crucial yet challenging, partly due to the limited diagnostic yield of noninvasive infectious tests. In this study, we report an antibiotic...
6.
Sanches Santos Rizzo Zuttion M, Parimon T, Bora S, Yao C, Lagree K, Gao C, et al.
J Clin Invest
. 2024 Sep;
134(21).
PMID: 39255040
A leading cause of mortality after influenza infection is the development of a secondary bacterial pneumonia. In the absence of a bacterial superinfection, prescribing antibacterial therapies is not indicated but...
7.
Clark J, Batra A, Tessier R, Greathouse K, Dickson D, Ammar A, et al.
Geroscience
. 2024 Sep;
47(1):189-203.
PMID: 39243283
The COVID-19 pandemic posed unprecedented challenges to healthcare systems worldwide, particularly in managing critically ill patients requiring mechanical ventilation early in the pandemic. Surging patient volumes strained hospital resources and...
8.
Lebrun-Corbin M, Cheung B, Hullahalli K, Dailey K, Bailey K, Waldor M, et al.
bioRxiv
. 2024 Sep;
PMID: 39229171
is a common nosocomial pathogen and a major cause of morbidity and mortality in hospitalized patients. Multiple reports highlight that gastrointestinal colonization may precede systemic infections by this pathogen. Gaining...
9.
Sumner J, Pickens C, Huttelmaier S, Moghadam A, Abdala-Valencia H, Hauser A, et al.
medRxiv
. 2024 Aug;
PMID: 39148859
The precise microbial determinants driving clinical outcomes in severe pneumonia are unknown. Competing ecological forces produce dynamic microbiota states in health; infection and treatment effects on microbiota state must be...
10.
Markov N, Ren Z, Senkow K, Grant R, Gao C, Malsin E, et al.
Nat Immunol
. 2024 Aug;
25(9):1607-1622.
PMID: 39138384
The evolution of T cell molecular signatures in the distal lung of patients with severe pneumonia is understudied. Here, we analyzed T cell subsets in longitudinal bronchoalveolar lavage fluid samples...